Rare coding variants in PLCG2, ABI3, and TREM2 implicate microglial-mediated innate immunity in Alzheimer's disease

Cited by (1,043)

Items 601–700 of 1,043

1. Development and validation of a 13-gene signature associated with immune function for the detection of Alzheimer's disease
   Min Zhu, Tingting Hou, Longfei Jia, Qihua Tan, Chengxuan Qiu, Yifeng Du · 2022 · Neurobiology of Aging
2. SQYZ granules, a traditional Chinese herbal, attenuate cognitive deficits in AD transgenic mice by modulating on multiple pathogenesis processes.
   Haiting An, Dongfeng Wei, Yanjing Qian, Ning Li, Xiaomin Wang · 2018 · Europe PMC (PubMed Central)
3. A single cell brain atlas in human Alzheimer’s disease
   Alexandra Grubman, Gabriel Chew, John F. Ouyang, Guizhi Sun, Xin Yi Choo, Catriona McLean, Rebecca K. Simmons, Sam Buckberry, Dulce B. Vargas-Landín, Jahnvi Pflueger et al. · 2019 · bioRxiv (Cold Spring Harbor Laboratory)
4. Brain aging and Alzheimer’s disease, a perspective from non-human primates
   Isidró Ferrer · 2024 · Aging
5. Role of central adiponectin and its interactions with NPY and GABAergic systems on food intake in neonatal layer chicken
   Sedigheh Madadi, Shahin Hasasnpour, Morteza Zendehdel, Bita Vazir, Alireza Jahandideh · 2023 · Neuroscience Letters
6. Epigenetic processes in Alzheimer's disease
   Isabel Castanho, Katie Lunnon · 2019 · Elsevier eBooks
7. Therapeutic targeting of neuroimmune mechanisms in neurodegeneration
   Kathryn M. Monroe, Soyon Youngae Hong, Joseph W. Lewcock, Andrew C. Yang · 2026 · Nature Reviews Drug Discovery
8. Cortical Thickness Differences Are Associated With Chemical Synaptic Transmission Upregulated Genes in Degeneration of Mild Cognitive Impairment
   Suping Cai, Kexin Huang, Fan Yang, Xuwen Wang, Sijia Wu, Yübo Wang, Liyu Huang · 2021 · Frontiers in Aging Neuroscience
9. Mechanistic Role of Jak3 in Obesity-Associated Cognitive Impairments
   Premranjan Kumar, Jayshree Mishra, Narendra Kumar · 2022 · Nutrients
10. Immune cells in Alzheimer’s disease: insights into pathogenesis and potential therapeutic targets
    Xiaofeng Fu, Huimin Cai, Shuiyue Quan, Ziye Ren, Yuyun Xu, Longfei Jia · 2024 · Medical Review
11. Exploiting formyl peptide receptor 2 to promote microglial resolution: a new approach to Alzheimer’s disease treatment
    Edward S. Wickstead, Murray A. Irving, Stephen J. Getting, Simon McArthur · 2021 · FEBS Journal
12. The dichotomous activities of microglia: A potential driver for phenotypic heterogeneity in Alzheimer’s disease
    Anna Pumo, Samuel Legeay · 2024 · Brain Research
13. X‐chromosome-wide association study for Alzheimer’s disease
    Julie Le Borgne, Lissette Gomez, Sami Heikkinen, Najaf Amin, Shahzad Ahmad, Seung Hoan Choi, Joshua C. Bis, Benjamin Grenier‐Boley, Omar Garcia Rodriguez, Luca Kleineidam et al. · 2024 · Molecular Psychiatry
14. Integrating rare pathogenic variant prioritization with gene‐based association analysis to identify novel genes and relevant multimodal traits for Alzheimer's disease
    Jixin Cao, Cheng Zhang, Chun‐Yi Zac Lo, Qihao Guo, Jing Ding, Xiaohui Luo, Zeji Zhang, Feng Chen, Tian‐Lin Cheng, Jingqi Chen et al. · 2024 · Alzheimer s & Dementia
15. An integrated brain-specific network identifies genes associated with neuropathologic and clinical traits of Alzheimer’s disease
    Cuixiang Lin, Hong‐Dong Li, Chao Deng, Weisheng Liu, Shannon Erhardt, Fang‐Xiang Wu, Xing‐Ming Zhao, Yuanfang Guan, Jun Wang, Daifeng Wang et al. · 2021 · Briefings in Bioinformatics
16. The role of triggering receptor expressed on myeloid cells 2 in Parkinson’s disease and other neurodegenerative disorders
    Hannah Schwarz, Sarah Bässler, Denise Balta, Eileen Socher, Friederike Zunke, Philipp Arnold · 2022 · Behavioural Brain Research
17. Three‐dimensional view of microglia—amyloid plaque interactions
    Maria Gotkiewicz, Janne Capra, Pasi O. Miettinen, Teemu Natunen, Heikki Tanila · 2024 · Glia
18. Benefits and Challenges of Rare Genetic Variation in Alzheimer’s Disease
    Detelina Grozeva, Salha Saad, Georgina Elizabeth Menzies, Rebecca Sims · 2019 · Current Genetic Medicine Reports
19. Alzheimer’s Disease and Dementia
    Patrick Alfryn Lewis, Jennifer E. Spillane · 2018 · Elsevier eBooks
20. eQTLs Weighted Genetic Correlation Analysis Detected Brain Region Differences in Genetic Correlations for Complex Psychiatric Disorders
    Yan Fei Wen, Feng Zhang, Xiancang Ma, Qianrui Fan, Wenyu Wang, Jiawen Xu, Feng Zhu, Jingcan Hao, Awen He, Li Liu et al. · 2018 · Schizophrenia Bulletin
21. Cell Type-Specific In Vitro Gene Expression Profiling of Stem Cell-Derived Neural Models
    James A. Gregory, Emily Hoelzli, Rawan Abdelaal, Catherine Braine, Miguel Cuevas, Madeline Halpern, Natalie Barretto, Nadine Schrode, Güney Akbalık, Kristy Kang et al. · 2020 · Cells
22. Current status of sevoflurane anesthesia in association with microglia inflammation and neurodegenerative diseases
    Yan‐Li Huang, Zhaoqiong Zhu · 2022 · Ibrain
23. Alzheimer’s disease-associated protective variant Plcg2-P522R modulates peripheral macrophage function in a sex-dimorphic manner
    Staley, Hannah A., Jernigan, Janna E., Bolen, MacKenzie L., Titus, Ann M., Neighbarger, Noelle, Cole, Cassandra, Menees, Kelly B., Wallings, Rebecca L., Tansey, Malú Gámez · 2024 · Journal of Neuroinflammation
24. Endothelial senescence alleviates cognitive impairment in a mouse model of Alzheimer 's disease
    Sayo Horibe, Takuo Emoto, Taiji Mizoguchi, Toru Tanaka, Shoji Kawauchi, Naoto Sasaki, Tomoya Yamashita, Koji Ikeda, Noriaki Emoto, Ken‐ichi Hirata et al. · 2023 · Glia
25. Mechanisms of increased Alzheimer’s Disease pathology with R47H and R62H TREM2 variants
    Nurun Nahar Fancy, Nanet Willumsen, Vicky M. N. Chau et al. · 2022 · medRxiv
26. Ethnic differences in the frequency of β-amyloid deposition in cognitively normal individuals
    Jaeho Kim, Sang‐Hyuk Jung, Yeong Sim Choe, Soyeon Kim, Beomsu Kim, Hang‐Rai Kim, Sang Joon Son, Chang Hyung Hong, Duk Lyul Na, Hee Jin Kim et al. · 2022 · Neurobiology of Aging
27. Set-Based Rare Variant Expression Quantitative Trait Loci in Blood and Brain from Alzheimer Disease Study Participants
    Devanshi Patel, Xiaoling Zhang, John J. Farrell, Kathryn L. Lunetta, Lindsay A. Farrer · 2021 · Genes
28. Is pseudoexfoliation glaucoma a neurodegenerative disorder?
    Biswajit Padhy, Debasmita Pankaj Alone · 2021 · Journal of Biosciences
29. Associations of plasma SMOC1 and soluble IL6RA levels with the progression from mild cognitive impairment to dementia
    Xavier Morató, Raquel Puerta, Amanda C. Cano, Adelina Orellana, Itziar de Rojas, María Capdevila, Laura Montrreal, Maitée Rosende‐Roca, Pablo García‐González, Clàudia Olivé et al. · 2024 · Brain Behavior & Immunity - Health
30. Variable and interactive effects of Sex, APOE ε4 and TREM2 on the deposition of tau in entorhinal and neocortical regions
    Joseph Giorgio, Caroline Jonson, Yilin Wang, Jennifer S. Yokoyama, Jingshen Wang, William J. Jagust, On behalf of the Alzheimer’s Disease Neuroimaging Initiative · 2025 · Nature Communications
31. Dysregulated AEBP1 and COLEC12 Genes in Late-Onset Alzheimer’s Disease: Insights from Brain Cortex and Peripheral Blood Analysis
    Mohamadreza Asadie, Ali Miri, Taleb Badri, Javad Hosseini Nejad, Javad Gharechahi · 2024 · Journal of Molecular Neuroscience
32. Rare variant burden analysis from exomes of three consanguineous families reveals LILRB1 and PRSS3 as potential key proteins in inflammatory bowel disease pathogenesis
    Rana Mohammed Jan, Huda Husain Al-Numan, Nada Hassan Al-Twaty, Nuha Mohammad Alrayes, Hadeel Ahmed Alsufyani, Meshari A. Alaifan, Bakr Hussain Alhussaini, Noor Ahmad Shaik, Zuhier Ahmed Awan, Yousef Abdulfattah Qari et al. · 2023 · Frontiers in Medicine
33. Systems biology of Alzheimer’s Disease: a scoping review of key pathways and mechanisms
    Paula J. Bice, Kwangsik T. Nho, Nilüfer Ertekin‐Taner, Andrew J. Saykin · 2026 · Molecular Neurodegeneration
34. Predicting the impact of missense mutations on an unresolved protein’s stability, structure, and function: A case study of Alzheimer’s disease-associated TREM2 R47H variant
    Joshua P. Pillai, Kijung Sung, Chengbiao Wu · 2025 · Computational and Structural Biotechnology Journal
35. Pro-resolving lipid mediator reduces amyloid-β42–induced gene expression in human monocyte–derived microglia
    Ying Wang, Xiang Zhang, Henrik Biverstål, Nicolas Guillermo Bazan, Shuai Tan, Nailin Li, Makiko Ohshima, Marianne Schultzberg, Xiaofei Li · 2024 · Neural Regeneration Research
36. Fluorogenic XY-69 in Lipid Vesicles for Measuring Activity of Phospholipase C Isozymes
    Adam J. Carr, Edhriz Siraliev-Perez, Weigang Huang, John Sondek, Qisheng Zhang · 2021 · Methods in molecular biology
37. Alzheimer’s Disease Neuropathological Change in Aged Non-Primate Mammals
    Isidró Ferrer · 2024 · International Journal of Molecular Sciences
38. Long-Term Pioglitazone Treatment Has No Significant Impact on Microglial Activation and Tau Pathology in P301S Mice
    Lea H. Kunze, François Ruch, Gloria Biechele, Florian Eckenweber, Karin Wind-Mark, Lina Dinkel, Paul Feyen, Peter Bartenstein, Sibylle Ilse Ziegler, Lars Paeger et al. · 2023 · International Journal of Molecular Sciences
39. What contribution can genetics make to predict the risk of Alzheimer's disease?
    Catherine Schramm, David Wallon, Gaël Nicolas, Camille Charbonnier · 2022 · Revue Neurologique
40. Rare variants in the endocytic pathway are associated with Alzheimer’s disease, its related phenotypes, and functional consequences
    Lingyu Zhan, Jiajin Li, Brandon Jew, Jae Hoon Sul · 2021 · PLoS Genetics
41. Alzheimer's disease–associated PLCG2 variants alter microglial state and function in human induced pluripotent stem cell–derived microglia‐like cells
    Bedford, Logan M., Tutrow, Kaylee D., Hooper, Karly, Messenger, Evan J., Hernandez, Melody, Lamb, Bruce T., Meyer, Jason S., Richardson, Timothy I., Bissel, Stephanie J. · 2025 · Alzheimer's & Dementia
42. Large‐scale sequencing studies expand the known genetic architecture of Alzheimer's disease
    Diane Xue, William S. Bush, Alan Edward Renton, Edoardo M. Marcora, Joshua C. Bis, Brian W. Kunkle, The Alzheimer's Disease Sequencing Project, Eric Boerwinkle, Anita L. DeStefano, Lindsay A. Farrer et al. · 2021 · Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring
43. ABI3 Is a Novel Early Biomarker of Alzheimer’s Disease
    Min Cao, Jing Liu, Xiaomin Zhang, Tingting Yang, Yaqi Wang, Yuli Hou, Song Qiao, Yuting Cui, Yifei Wang, Peichang Wang · 2022 · Journal of Alzheimer s Disease
44. Antidepressants as a potential candidate to reduce microglia activation in neurodegenerative diseases. A systematic review and meta-analysis of preclinical studies
    Lisa Nicolai, Pauline Nettesheim, Lot D. de Witte, Gijsje J. L. Snijders · 2023 · Journal of Affective Disorders Reports
45. Role and application of CRISPR-Cas9 in the management of Alzheimer’s disease
    Nilay Soni, Indrani Kar, Jadav Dhruvkumar Narendrasinh, Sanjay Kumar Shah, Lohini Konathala, Nadine Mohamed, Meet Popatbhai Kachhadia, Mitul Hareshkumar Chaudhary, Vyapti A. Dave, Lakshya Kumar et al. · 2024 · Annals of Medicine and Surgery
46. Genetic analysis of cognitive preservation in the midwestern Amish reveals a novel locus on chromosome 2
    Leighanne R. Main, Yeunjoo E. Song, Audrey Lynn, Reneé A. Laux, Kristy L. S. Miskimen, Michael D. Osterman, Michael L. Cuccaro, Paula K. Ogrocki, Alan Jay Lerner, Jeffery M. Vance et al. · 2024 · Alzheimer s & Dementia
47. Erosion of Gene Co-expression Networks Reveal Deregulation of Immune System Processes in Late-Onset Alzheimer’s Disease
    John Stephen Malamon, Andres Kriete · 2020 · Frontiers in Neuroscience
48. Analysis of pedigree data in populations with multiple ancestries: Strategies for dealing with admixture in Caribbean Hispanic families from the ADSP
    Rafael Albertovich Nafikov, Alejandro Q. Nato, Harkirat K. Sohi, Bowen Wang, Lisa A. Brown, Andréa R. V. R. Horimoto, Badri Narayan Vardarajan, Sandra Barral, Giuseppe Tosto, Richard P Mayeux et al. · 2018 · Genetic Epidemiology
49. Deletion of the Alzheimer’s disease risk gene Abi3 locus results in obesity and systemic metabolic disruption in mice
    Smith, Daniel C., Karahan, Hande, Wijeratne, H. R. Sagara, Al-Amin, Mamun, McCord, Brianne, Moon, Younghye, Kim, Jungsu · 2022 · Frontiers in Aging Neuroscience
50. The WAVE complex in developmental and adulthood brain disorders
    Kim, Hyung-Goo, Berdasco, Clara, Nairn, Angus C., Kim, Yong · 2025 · Experimental & Molecular Medicine
51. The Alzheimer’s disease risk genes MS4A4A and MS4A6A cooperate to negatively regulate TREM2 and microglia states
    Dalya Rosner, Jiahong Sun, Rita Cacace, Angie Yee, Chaitanya Wagh, Anna Rychkova, Mariah Dunlap, Daniel R. Gulbranson, Adiljan Ibrahim, Xiaoting Wang et al. · 2025 · Neuron
52. Lessons from genetic studies in Alzheimer disease
    Gaël Nicolas · 2024 · Revue Neurologique
53. Shared Mechanisms in Dementia and Depression: The Modulatory Role of Physical Exercise
    Pedro Borges de Souza, Ana Lúcia S. Rodrigues, Fernanda G. De Felice · 2025 · Journal of Neurochemistry
54. Genetic Ablation of Hematopoietic Cell Kinase Accelerates Alzheimer’s Disease–Like Neuropathology in Tg2576 Mice
    Sharon Lim, Diana Nguyen Tran, Zanett Kieu, Christine Chen, Emmanuel Villanueva, Sagar Ghiaar, Victoria Gallup, Joannee Zumkehr, David H. Cribbs, Carlos J. Rodríguez‐Ortiz et al. · 2020 · Molecular Neurobiology
55. Aberrant accumulation of age- and disease-associated factors following neural probe implantation in a mouse model of Alzheimer’s disease
    Steven M. Wellman, Olivia Coyne, Madeline M. Douglas, Takashi D.Y. Kozai · 2023 · Journal of Neural Engineering
56. Alzheimer’s disease Phospholipase C-gamma-2 (PLCG2) protective variant is a functional hypermorph
    2018
57. Centenarian Controls Increase Variant Effect-sizes by an average two-fold in an Extreme Case-Extreme Control Analysis of Alzheimer’s Disease
    2018
58. Genotype–phenotype correlation of T-cell subtypes reveals senescent and cytotoxic genes in Alzheimer’s disease
    Dallin Dressman, Thomas Buttrick, Maria Cimpean, David Alan Bennett, Vilas Menon, Elizabeth M. Bradshaw, Badri Narayan Vardarajan, Wassim Elyaman · 2022 · Human Molecular Genetics
59. Novel Rare SORL1 Variants in Early-Onset Dementia
    Anita Korpioja, Johanna Krüger, Susanna Koivuluoma, Katri Pylkäs, Virpi Moilanen, Seppo Helisalmi, Mikko O. Hiltunen, Anne Marja Remes · 2021 · Journal of Alzheimer s Disease
60. Characterisation of molecular mechanisms for PLCγ2 disease-linked variants
    Bunney, Tom D., Kampyli, Charis, Gregory, Ashley, Katan, Matilda · 2024 · Advances in Biological Regulation
61. Study of Alzheimer's disease- and frontotemporal dementia-associated genes in the Cretan Aging Cohort
    Lambros Mathioudakis, Christina Dimovasili, Mara Bourbouli, Helen Latsoudis, Evgenia Kokosali, Garyfallia Gouna, Emmanouella Vogiatzi, Maria Basta, Stefania Kapetanaki, Simeon Panagiotakis et al. · 2022 · Neurobiology of Aging
62. Integrating explainable machine learning and transcriptomics data reveals cell-type specific immune signatures underlying macular degeneration
    Khang Ma, Hosei Nakajima, Nipa Basak, Arko Barman, Rinki Ratnapriya · 2025 · npj Genomic Medicine
63. Overexpression of PLCG2 and TMEM38A inhibit tumor progression in clear cell renal cell carcinoma
    Yiqiao Zhao, Liang Yang, Xiaojie Bai, Lu Du, Huan Lai, Yiyang Liu, Ping Chen, Michael E. DiSanto, Xinhua Zhang · 2025 · Scientific Reports
64. The crystal and cryo-EM structures of PLCγ2 reveal dynamic interdomain recognitions in autoinhibition
    Shin, Young-Cheul, Plummer-Medeiros, Ashlee Marie, Mungenast, Alison, Choi, Hyeong-wook, TenDyke, Karen, Zhu, Xiaojie, Shepard, Jennifer, Sanders, Kristen, Zhuang, Ningning, Hu, Liang et al. · 2024 · Science Advances
65. Non-Communicable Neurological Disorders and Neuroinflammation
    Clara Ballerini, Alfred Kongnyu NJAMNSHI, Sharon L. Juliano, Raj N. Kalaria, Roberto Furlan, Rufus Akinyemi · 2022 · Frontiers in Immunology
66. An insight into Alzheimer’s disease and its on-setting novel genes
    Jaanaky Vigneswaran, Sivaloganathan Anogh Muthukumar, Mohamed Shafras, Geetika Pant · 2021 · The Egyptian Journal of Neurology Psychiatry and Neurosurgery
67. Molecular estimation of neurodegeneration pseudotime in older brains
    2019
68. Glial Cells in Alzheimer’s Disease: Pathogenic Mechanisms and Therapeutic Frontiers
    Moumita Sil, Nabanita Mukherjee, Ishita Chatterjee, Ankita Ghosh, Arunava Goswami · 2025 · Journal of Molecular Neuroscience
69. PLCG2 as a Risk Factor for Alzheimer's Disease.
    Tsai, Andy P., Dong, Chuanpeng, Preuss, Christoph, Moutinho, Miguel, Lin, Peter Bor-Chian, Hajicek, Nicole, Sondek, John, Bissel, Stephanie J., Oblak, Adrian L., Carter, Gregory W. et al. · 2020
70. The intrinsically disordered cytoplasmic tail of a dendrite branching receptor uses two distinct mechanisms to regulate the actin cytoskeleton
    Kramer, Daniel A, Narvaez-Ortiz, Heidy Y, Patel, Urval, Shi, Rebecca, Shen, Kang, Nolen, Brad J, Roche, Julien, Chen, Baoyu · 2023 · eLife
71. The Early‐Onset Alzheimer's Disease Whole‐Genome Sequencing Project: Study design and methodology
    Nicholas R. Ray, Temitope Ayodele, Melissa N. Jean‐Francois, Penelope Baez, María Victoria Fernández, Joseph L. Bradley, Paul K. Crane, Clifton L. Dalgard, Amanda B Kuzma, Heather Issen Nicaretta et al. · 2023 · Alzheimer s & Dementia
72. Molecular Dynamics simulations of Alzheimer’s variants, R47H and R62H, in TREM2 provide evidence for structural alterations behind functional changes
    Georgina Elizabeth Menzies, Rebecca Sims, Julie H. Williams · 2019 · bioRxiv (Cold Spring Harbor Laboratory)
73. Soluble CSF1R promotes microglial activation and amyloid clearance in Alzheimer’s disease
    Zhang, Lianshuai, Chen, Kai, Zeng, Ruicheng, Bu, Guojun, Chen, Xiao-Fen · 2025 · Journal of Neuroinflammation
74. Identification and Quantitation of Novel ABI3 Isoforms Relative to Alzheimer’s Disease Genetics and Neuropathology
    Turner, Andrew K., Shaw, Benjamin C., Simpson, James F., Estus, Steven · 2022 · Genes
75. Inhibitory Fcγ Receptor and Paired Immunoglobulin Type 2 Receptor Alpha Genotypes in Alzheimer’s Disease
    Janardan P. Pandey, Aryan M. Namboodiri, Paul J. Nietert, Lisa Laverne Barnes, David Alan Bennett · 2021 · Journal of Alzheimer s Disease
76. Weakly activated core inflammation pathways were identified as a central signaling mechanism contributing to the chronic neurodegeneration in Alzheimer’s disease
    Fuhai Li, Abdallah M. Eteleeb, William Buchser, Guoqiao Wang, Chengjie Xiong, Philip Payne, Eric McDade, Celeste M M. Karch, Oscar Harari, Carlos Cruchaga · 2021 · bioRxiv (Cold Spring Harbor Laboratory)
77. The contribution of Neanderthal introgression and natural selection to neurodegenerative diseases
    Zhongbo Chen, Regina Hertfelder Reynolds, Antonio F. Pardiñas, Sarah A. Gagliano Taliun, Wouter van Rheenen, Kuang Lin, Aleksey Shatunov, Emil Karl Gustavsson, Isabella Fogh, Ashley R. Jones et al. · 2023 · Neurobiology of Disease
78. Chromosome X-wide association study in case control studies of pathologically confirmed Alzheimer’s disease in a European population
    Emily Simmonds, Ganna Leonenko, Ümran Yaman, Eftychia Bellou, Amanda Myers, Kevin Morgan, Keeley J. Brookes, John Hardy, Dervis A. M. Salih, Valentina Escott‐Price · 2024 · Translational Psychiatry
79. Inferring the molecular mechanisms of noncoding Alzheimer’s disease-associated genetic variants
    2018
80. Predictive Value of Gut Microbiome for Cognitive Impairment in Patients with Hypertension
    Shourong Lu, Lin Shao, Yunyun Zhang, Ying Yang, Zhuo Wang, Bingshan Zhang, Jie Zhong Yu, Qiao Xu, Shuqiang Wang, Xiaorong Chen et al. · 2021 · Disease Markers
81. Alzheimer diseases
    Alena V. Savonenko, Philip C. Wong, Tong Li · 2022 · Elsevier eBooks
82. Associations between rare microglia‐linked Alzheimer's disease risk variants and subcortical brain volumes in young individuals
    Thomas Matthew Lancaster · 2019 · Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring
83. Stem cell derived human microglia transplanted in mouse brain to study genetic risk of Alzheimer’s Disease
    2019
84. Computational saturation mutagenesis to explore the effect of pathogenic mutations on extra-cellular domains of TREM2 associated with Alzheimer’s and Nasu-Hakola disease
    Preety Sthutika Swain, Sunita Panda, Sanghamitra Pati, Budheswar Dehury · 2023 · Journal of Molecular Modeling
85. Structural biology of cell surface receptors implicated in Alzheimer’s disease
    Stefan J. Hermans, Tracy L. Nero, Craig J. Morton, Jonathan H. Gooi, Gabriela A. N. Crespi, Nancy C. Hancock, Chen Gao, Kenta Ishii, Jasmina Markulić, Michael W. Parker · 2021 · Biophysical Reviews
86. A rare heterozygous TREM2 coding variant identified in familial clustering of dementia affects an intrinsically disordered protein region and function of TREM2
    Meliha Karsak, Konstantin Glebov, Marina Scheffold, Thomas Bajaj, Amit Kawalia, Ilker Karaca, Sebastian Rading, Johannes Kornhuber, Oliver Peters, Mónica Díez-Fairén et al. · 2019 · Human Mutation
87. Distinct inflammatory profiles in young‐onset versus late‐onset Alzheimer's disease
    Simrika Thapa, Chloe Anastassiadis, Anna Vasilevskaya, Foad Taghdiri, Igor Jurišica, Mohsen Hadian, Patrick Salwierz, Faiza Robbani, Pia Kivisäkk, Bradley T. Hyman et al. · 2025 · Alzheimer s & Dementia
88. Genomics of Alzheimer’s disease
    Margot P. van de Weijer, Iris E. Jansen, Anouk H. A. Verboven, Ole A. Andreassen, Danielle Posthuma B · 2019 · Elsevier eBooks
89. Immune response and endocytosis pathways are associated with the resilience against Alzheimer’s Disease
    2019
90. Screening for Core Genes Related to Pathogenesis of Alzheimer’s Disease
    Long-Xiu Yang, Yuan Han Qin, Chongdong Jian · 2021 · Frontiers in Cell and Developmental Biology
91. A comparative study of structural variant calling in WGS from Alzheimer’s disease families
    John Stephen Malamon, John J. Farrell, Li Charlie Xia, Beth A. Dombroski, Gautami Das, Jessica Way, Amanda B Kuzma, Otto Valladares, Yuk Yee Leung, Allison J. Scanlon et al. · 2024 · Life Science Alliance
92. The Alzheimer’s Disease Risk Genes MS4A4A And MS4A6A Cooperate to Negatively Regulate Trem2 and Microglia states
    2024
93. Low frequency and rare coding variation contributes to multiple sclerosis risk
    Mitja Mitrovič, Nikolaos A. Patsopoulos, Ashley Harris Beecham, Theresa Dankowski, An Goris, Bénédicte Dubois, Marie Beatrice D'hooghe, Robin Lemmens, Philip Van Damme, Kate Fitzgerald et al. · 2018 · bioRxiv (Cold Spring Harbor Laboratory)
94. Alzheimer's disease: the large gene instability hypothesis
    Sourena Soheili‐Nezhad · 2017 · bioRxiv (Cold Spring Harbor Laboratory)
95. A genome-wide association study in Peruvians suggests new risk loci for Alzheimer Disease
    Bilçağ Akgün, Mario Cornejo‐Olivas, Nilton Custodio, Pedro Ramon Mena, Marcio Soto‐Añari, Rosa Montesinos, Larry Deon Adams, Katrina Celis, Zikun Yang, Basilio Cieza Huaman et al. · 2023 · medRxiv
96. Alzheimer's disease knowledge graph enhances knowledge discovery and disease prediction
    Yue Yang, Kaixian Yu, Shan Gao, Sheng Yu, Di Xiong, Chuanyang Qin, Huiyuan Chen, Jiarui Tang, Niansheng Tang, Hongtu Zhu B · 2025 · Computers in Biology and Medicine
97. Genetics and Epigenetics of Alzheimer’s Disease: Understanding Pathogenesis and Exploring Therapeutic Potential
    Prabhakar Tiwari, Rekha Dwivedi, Meenakshi Kaushik, Manjari Tripathi, Rima Dada · 2025 · Journal of Molecular Neuroscience
98. A coming era of precision diagnostics based on nano-assisted mass spectrometry
    Rongxin Li, Deepanjali Dattatray Gurav, Jingjing Wan, Kun Qian · 2018 · Precision Nanomedicine
99. Impact of Sleep on Autophagy and Neurodegenerative Disease: Sleeping Your Mind Clear
    Samuel Deutsch, Bilal R. Malik · 2022 · Archives of Molecular Biology and Genetics
100. PLCG2 across human disease: genetic variants, signaling mechanisms, and clinical implications
     Ping Jiang, Mingcong Wang, Chengzhe Zhang, Xiaopeng Li, Zhi qiang Wang, Yajuan Guo, Juhua Zhang, Wei Yan, Xiaobing Xi · 2026 · Journal of Translational Medicine